Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans

Diabetes

Volumn 49, Issue 5, 2000, Pages 701-707

  Roden, Michael ^a   Stingl, Harald ^a   Chandramouli, Visvanathan ^b   Schumann, William C ^b   Hofer, Astrid ^a   Landau, Bernard R ^b   Nowotny, Peter ^a   Waldhäusl, Werner ^a   Shulman, Gerald I ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; DEUTERIUM; FATTY ACID; GLUCAGON; GLUCOSE; GLYCEROL; GROWTH HORMONE; HEPARIN; HYDROCORTISONE; INSULIN; INTRALIPID; LACTIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL;

EID: 0034072554     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.5.701     Document Type: Article

References (49)

1. Felber J-P, Ferrannini E, Golay A, Meye HU, Thiebaud D, Curchod B, Maeder K, Jequier E, DeFronzo RA: Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350, 1987
2. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD: Measurement of plasma glucose free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024, 1988
3. Perseghin G, Ghosh S, Gerow K, Shulman GI: Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-1009, 1997
4. McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770, 1992
5. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:13-10, 1997
6. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ: Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92:91-98, 1993
7. Roden M, Price TB, Perseghin G, Falk-Petersen K, Rothman DL, Cline GW, Shulman GI: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865, 1996
8. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fürnsinn C, Moser E, Waldhäusl W: Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48:358-364, 1999
9. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D: Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238-1246, 1984
10. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes niellitus. J Clin Endocrinol Metab 72:96-107, 1991
11. Saloranta C, Koivisto V, Widen E, Falholt K, DeFronzo RA, Harkonen M, Groop L: Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 264:E599-E605, 1993
12. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA: Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747, 1983
13. Bonadonna RC, Zych K, Boni C, Ferrannini E, DeFronzo RA: Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 257:E49-E56, 1989
14. Yki-Järvinen H, Puhakainen I, Saloranta C, Groop L, Taskinen MR: Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 260:E680-E689, 1991
15. Boden G, Jadali F: Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 40:686-692, 1991
16. Clore JN, Glickman PS, Nestler JE, Blackard WG: In vivo evidence for hepatic autoregulation during FFA-stimulaled gluconeogenesis in normal humans. Am J Physiol 261:E425-E429, 1991
17. Fulcher GR, Walker M, Catalano C, Agius L, Alberti KG: Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 41:1400-1408, 1992
18. Chen X, Iqbal N, Boden G: The effect of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103:305-372, 1999
19. Vaag A, Skött P, Gall M-A, Richter EA, Beck-Nielsen H: Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 88:1282-1290, 199I
20. Puhakainen I, Yki-Järvinen H: Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 42:1694-1699, 1993
21. 13C nuclear magnetic resonance study. J Clin Invest 90:1323-1327, 1992
22. Gerich JE, Nurjhan N: Gluconeogenesis in type 2 diabetes. Adv Exp Med Biol 334:253-258, 1993
23. Fery F, Plat L, Melot C, Balasse EO: Role of fat-derived substrates in the regulation of gluconeogenesis during fasting. Am J Physiol 270:E822-E830, 1996
24. Waldhäusl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P: Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic type 2 (non-insulin-dependent) diabetes mellitus. Diabelologia 23:6-15, 1982
25. Landau BR: Estimating gluconeogenic rates in NIDDM. Adv Exp Med Biol 334:205-220, 1992
26. 14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. J Biol Chem 266:6985-6990, 1991
27. Landau BR, Fernandez CA, Previs SF, Ekberg K, Chandramouli V, Wahren J, Kalhan SC, Brunengraber H: A limitation in the use of mass isotopomer distributions to measure gluconeogenesis in fasting humans. Am J Physiol 269:E18-E26, 1995
28. 2O for estimating rates of gluconeogenesis: application to the fasted state. J Clin Invest 95:172-178, 1995
29. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC: Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98:378-385, 1996
30. Chandramouli V, Ekberg K, Schumann WC, Kalhan SC, Wahren J, Landau BR: Quantifying gluconeogenesis during fasting. Am J Physiol 36:E1209-1215, 1997
31. 3H-glucose infusion. Diabetologia 33:603-610, 1990
32. Waldhäusl W, Herkner K, Nowotny P, Bratusch-Marrain P: Combined 17- and 18-hydroxylase deficiency associated with complete male pseudohermaphroditism and hypoaldosteronism. J Clin Endocrinol Metab 46:236-240, 1978
33. Boden G, Cgen X, Rosner J, Barton M: Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239-1242, 1995
34. Pelkonen R, Miettinen TA, Taskinen M-R, Nikkila EA: Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma insulin. Diabetes 17:76-82, 1968
35. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, McGarry JD: Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728-2735, 1996
36. Blackard WG, Nelson NC: Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes 19:302-306, 1970
37. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest 84:205-213, 1989
38. Sindelar DK, Igawa K, Chu CA, Balcom JH, Neal DW, Cherrington AD: Effect of a selective rise in hepatic artery insulin on hepatic glucose production in the conscious dog. Am J Physiol 276:E806-E813, 1999
39. Roden M, Perseghin G, Falk Petersen K, Hwang J-H, Cline GW, Gerow K, Rothman DL, Shulman GI: The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 97:642-648, 1996
40. Nurjhan N, Campbell PJ, Kennedy FP, Miles JM, Gerich JE: Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes 35:1326-1331, 1986
41. Previs S, Cline GW, Shulman GI: A critical evaluation of mass isotopomer distribution analysis of gluconeogenesis in vivo. Am J Physiol 277:E154-E160, 1999
42. Wahren J, Hagenfeldt L, Felig P: Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus. J Clin Invest 55:1303-1314, 1975
43. Bahl JJ, Matsuda M, DeFronzo KA, Bressler R: In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase. Biochem Pharmacol 53:67-74, 1997
44. Youn H, Bergman RN: Enhancement of hepatic glycogen by gluconeogenic precursois: substrate flux or metabolic control? Am J Physiol 258:E899-E906, 1990
45. Chandramouli V, Ekberg K, Schumann WC, Wahren J, Landau BR: Origins of the hydrogen bound to carbon 1 of glucose in fasting: significance in gluconeogenesis quantitation. Am J Physiol 277:E717-E723, 1999
46. Peterson KF, Laurent D, Rothman DL, Cline GW, Shulman GI: Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101:1203-1209, 1998
47. Magnusson I, Chandramouli Y, Schumann WC, Kumaran K, Wahren J, Landau BR: Pentose pathway in human liver. Proc Natl Acad U S A 85:4682-4685, 1988
48. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman FL, Petersen KF, Shulman GI: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259, 1999
49. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acids as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995